Dyno Therapeutics CEO and co-founder Eric Kelsic, PhD, likens his company’s development of transformative AI-designed adeno-associated virus (AAV) vectors for gene therapy to climbing a mountain—a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback